More importantly, to reinforce Blanchette’s findings, another study from a clinical standpoint revealed that the combined expression profile of hepcidin and ferroportin serves as a potent predictor for survival following mastectomy for women with breast cancer (55). Here, SLC40A1 is linked to breast carcinoma.